The ocular safety of hydroxychloroquine

Seminars in Arthritis and Rheumatism

Volumn 23, Issue 2, 1993, Pages 62-67

  Easterbrook, Michael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amsler; color vision; Hydroxychloroquine; keratopathy; maculopath; ocular safety

Indexed keywords

AMIODARONE; ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE;

ARTICLE; COLOR VISION; CORNEA; DRUG EXCRETION; DRUG SAFETY; DRUG TISSUE LEVEL; EVOKED VISUAL RESPONSE; EYE TOXICITY; HUMAN; KERATOPATHY; MAJOR CLINICAL STUDY; PERIMETRY; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA DEGENERATION; RETINA MACULOPATHY; RETINOPATHY; RHEUMATOLOGY; SCOTOMA; SLIT LAMP; VISUAL FIELD DEFECT; DOSE CALCULATION; EARLY DIAGNOSIS; LONG TERM CARE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RHEUMATOID ARTHRITIS; FEMALE; IATROGENIC DISEASE; INCIDENCE; MALE; PROSPECTIVE STUDY; RETINA DISEASE; VISION TEST;

FEMALE; HUMAN; HYDROXYCHLOROQUINE; INCIDENCE; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RETINAL DISEASES; SCOTOMA; VISION TESTS;

EID: 0027487941     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(10)80009-5     Document Type: Article

References (25)

1. Unusual ocular lesions in a case of systemic lupus erythematosus
2. Ocular complications of chloroquine therapy
3. The ocular complications of chloroquine retinopathy
4. Ocular lesions after treatment with chloroquine
5. Antimalarials in rheumatology: efficacy and safety
6. Is corneal deposition of antimalarial any indication of toxicity?
7. Ocular effects and safety of antimalarial agents
8. Comparison of hydroxychloroquine and chloroquine in the development of retinal toxicity
9. Ocular safety of hydroxychloroquine
10. Hydroxychloroquine retinopathy
11. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials
12. Melanin: Blackguard or red herring? Another look at chloroquine retinopathy
13. Hydroxychloroquine therapy in massive total doses without retinal toxicity
14. Hydroxychloroquine: Seven-year experience
15. Dose relationships in patients with early chloroquine retinopathy
16. Long-term course of antimalarial maculopathy after cessation of treatment
17. The use of Amsler grids in early chloroquine retinopathy
18. Complications of antimalarial therapy
19. The sensitivity of Amsler grids in early chloroquine retinopathy
20. Comparison of threshold Amsler grid testing and standard grid testing in patients with established antimalarial retinopathy
21. Evaluation of several tests in screening for chloroquine maculopathy
22. Chloroquine and the eye
23. The value of Humphrey perimetry in the detection of early chloroquine retinopathy
24. Screening for hydroxychloroquine retinal toxicity: Is it necessary?
25. Screening for antimalarial toxicity